Browse every story filed under this topic, curated from trusted publishers around the world.
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder | TechCrunch
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
Read full story →
Stripe introduces Link, a digital wallet that autonomous AI agents can use, too | TechCrunch
Link lets users connect cards, banks, and subscriptions, then authorize AI agents to spend securely via approval flows.
Inter still have Nico Paz hope despite Real Madrid return with Mourinho potentially involved
According to Corriere dello Sport, Inter remain interested in Como talent Nico Paz, who is set to return to Real …
Axoft Secures $55M for Implantable Brain-Computer Interfaces and Fleuron™ Material Global Trials
What You Should Know Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total …
Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
As Ekterly nears the one-year anniversary of its approval, Chiesi Group is making moves to acquire the rare disease med …
Polymarket seeks US return with CFTC approval
Polymarket blocked US traders after a 2022 CFTC settlement and moved its exchange overseas.
Trump approval slips to record low of current term: Survey
A new poll shows President Trump’s approval rating has slipped to the lowest level of his second term, with more …
Reload, not rebuild
Apr. 28—MOSES LAKE — On Friday, Moses Lake Athletics Director Loren Sandhop announced Kyler Haneberg as the new head football …
Baystate to acquire Trinity Health hospital
Springfield, Mass.-based Baystate Health has signed a definitive agreement to acquire a financially challenged hospital in the city from Hartford, …
FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
The FDA has told Amgen that it is proposing to withdraw the approval of the rare disease drug Tavneos. The …
Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease priority review voucher, striking a $180 million sale that reflects …
With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
After recalibrating its production strategy in the late 2010s to help meet the realities of the CAR-T market, Gilead Sciences’ …
FDA weighs pulling Amgen drug
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of Tavneos (avacopan) after determining the drug has …
Milestone for CRISPR: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial
A biotech company is looking to get approval next after their recent discovery.
Compass Therapeutics’s stock crashes after OS miss in BTC trial
Compass Therapeutics will still submit tovecimig for approval despite the OS miss in BTC. The post Compass Therapeutics’s stock crashes …
Cellenkos receives FDA approval for CK0801 Phase II clinical trial
Cellenkos has received FDA clearance to begin its Phase II clinical trial of CK0801 for the treatment of aplastic anaemia. …
FDA approves AstraZeneca’s Saphnelo for SLE
AstraZeneca has received approval from the FDA for the subcutaneous self-administration of Saphnelo using the Saphnelo pen for SLE.
‘My understanding is…’ – Romano drops Alisson update as Juventus prepare to make their move
Fabrizio Romano has shared details of Juventus’ plans to offer a ‘long-term’ contract to Alisson Becker.Reports from Italy last week …
Intellia’s Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to …
California billionaire tax has enough signatures for ballot, backers say
Advocates for a proposed California billionaire tax said on Sunday they received enough signatures for the measure to appear on …
You've seen all articles for #approval.
Check back
soon
for new stories.